Ironwood Pharmaceuticals, Inc. (IRWD)
4.28
+0.03
(+0.71%)
USD |
NASDAQ |
Sep 01, 14:54
Ironwood Pharmaceuticals Total Long Term Debt (Quarterly) : 393.58M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 393.58M |
| March 31, 2026 | 594.09M |
| December 31, 2025 | 594.55M |
| September 30, 2025 | 595.00M |
| June 30, 2025 | 595.45M |
| March 31, 2025 | 595.88M |
| December 31, 2024 | 596.29M |
| September 30, 2024 | 611.70M |
| June 30, 2024 | 637.10M |
| March 31, 2024 | 687.28M |
| December 31, 2023 | 712.41M |
| September 30, 2023 | 737.54M |
| June 30, 2023 | 812.66M |
| March 31, 2023 | 412.76M |
| December 31, 2022 | 412.85M |
| September 30, 2022 | 412.94M |
| June 30, 2022 | 413.02M |
| March 31, 2022 | 533.66M |
| December 31, 2021 | 472.68M |
| September 30, 2021 | 466.97M |
| June 30, 2021 | 461.40M |
| March 31, 2021 | 455.94M |
| December 31, 2020 | 450.57M |
| September 30, 2020 | 445.31M |
| June 30, 2020 | 440.14M |
| Date | Value |
|---|---|
| March 31, 2020 | 435.06M |
| December 31, 2019 | 430.08M |
| September 30, 2019 | 425.34M |
| June 30, 2019 | 420.21M |
| March 31, 2019 | 486.00M |
| December 31, 2018 | 413.92M |
| September 30, 2018 | 409.31M |
| June 30, 2018 | 407.15M |
| March 31, 2018 | 403.69M |
| December 31, 2017 | 400.17M |
| September 30, 2017 | 396.34M |
| June 30, 2017 | 392.96M |
| March 31, 2017 | 389.41M |
| December 31, 2016 | 372.80M |
| September 30, 2016 | 374.73M |
| June 30, 2016 | 377.12M |
| March 31, 2016 | 379.52M |
| December 31, 2015 | 381.48M |
| September 30, 2015 | 445.68M |
| June 30, 2015 | 452.27M |
| March 31, 2015 | 174.81M |
| December 31, 2014 | 177.32M |
| September 30, 2014 | 178.74M |
| June 30, 2014 | 178.98M |
| March 31, 2014 | 178.69M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 39.29M |
| AbbVie, Inc. | 70.82B |
| Marker Therapeutics, Inc. | 0.00 |
| Theriva Biologics, Inc. | 3.028M |
| Fortress Biotech, Inc. | 46.07M |